Authors:
Hadlock, KG
Gish, R
Rowe, J
Rajyaguru, SS
Newsom, M
Warford, A
Foung, SKH
Citation: Kg. Hadlock et al., Cross-reactivity and clinical impact of the antibody response to hepatitisC virus second envelope glycoprotein (E2), J MED VIROL, 65(1), 2001, pp. 23-29
Authors:
Quinn, ER
Chan, CH
Hadlock, KG
Foung, SKH
Flint, M
Levy, S
Citation: Er. Quinn et al., The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis, BLOOD, 98(13), 2001, pp. 3745-3749
Citation: Ch. Chan et al., V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen, BLOOD, 97(4), 2001, pp. 1023-1026
Authors:
Hadlock, KG
Lanford, RE
Perkins, S
Rowe, J
Yang, Q
Levy, S
Pileri, P
Abrignani, S
Foung, SKH
Citation: Kg. Hadlock et al., Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes, J VIROLOGY, 74(22), 2000, pp. 10407-10416
Citation: Kg. Hadlock et al., The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes, J VIROLOGY, 73(2), 1999, pp. 1205-1212